Gene · 3635
Papers3,499
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,499
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Conventional, Complementary and Alternative Medicines: Mechanistic Insights into Therapeutic Landscape of Chronic Obstructive Pulmonary Disease. | Int J Chron Obstruct Pulmon Dis | 2023 | 37038544 | PubTator, text mining | PubMed |
| The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer. | Nat Commun | 2023 | 37031249 | PubTator, text mining | PubMed |
| A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology. | Ther Adv Med Oncol | 2023 | 37025260 | PubTator, text mining | PubMed |
| Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer's disease. | Trends Neurosci | 2023 | 37019812 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature. | Front Mol Neurosci | 2023 | 37008787 | PubTator, text mining | PubMed |
| Mapping the SLP76 interactome in T cells lacking each of the GRB2-family adaptors reveals molecular plasticity of the TCR signaling pathway. | Front Immunol | 2023 | 37006259 | PubTator, text mining | PubMed |
| Bortezomib advanced mechanisms of action in multiple myeloma, solid and liquid tumors along with its novel therapeutic applications. | EXCLI J | 2023 | 36998701 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitors in HBV-Caused Hepatocellular Carcinoma Therapy. | Vaccines (Basel) | 2023 | 36992198 | PubTator, text mining | PubMed |
| The Negative Impact of Triptolide on the Immune Function of Human Natural Killer Cells. | Pharmaceuticals (Basel) | 2023 | 36986557 | PubTator, text mining | PubMed |
| Kaempferol Suppresses the Activation of Mast Cells by Modulating the Expression of FcεRI and SHIP1. | Int J Mol Sci | 2023 | 36983066 | PubTator, text mining | PubMed |
| Expression of INPP5D Isoforms in Human Brain: Impact of Alzheimer's Disease Neuropathology and Genetics. | Genes (Basel) | 2023 | 36981033 | PubTator, text mining | PubMed |
| The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer-Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy. | Cancers (Basel) | 2023 | 36980527 | PubTator, text mining | PubMed |
| MicroRNA-155 and Disease-Related Immunohistochemical Parameters in Cutaneous Melanoma. | Diagnostics (Basel) | 2023 | 36980512 | PubTator, text mining | PubMed |
| Exosomal Non-Coding RNAs: Novel Regulators of Macrophage-Linked Intercellular Communication in Lung Cancer and Inflammatory Lung Diseases. | Biomolecules | 2023 | 36979471 | PubTator, text mining | PubMed |
| Nectin Family Ligands Trigger Immune Effector Functions in Health and Autoimmunity. | Biology (Basel) | 2023 | 36979144 | PubTator, text mining | PubMed |
| Microglial Phagocytosis/Cell Health High-Content Assay. | Curr Protoc | 2023 | 36971657 | PubTator, text mining | PubMed |
| Study of the shared gene signatures of polyarticular juvenile idiopathic arthritis and autoimmune uveitis. | Front Immunol | 2023 | 36969183 | PubTator, text mining | PubMed |
| Activated Src kinases downstream of BCR-ABL and Flt3 induces proteasomal degradation of SHIP1 by phosphorylation of tyrosine 1021. | Biochim Biophys Acta Mol Cell Res | 2023 | 36958526 | PubTator, text mining | PubMed |
| PI3Kα Translocation Mediates Nuclear PtdIns(3,4,5)P3 Effector Signaling in Colorectal Cancer. | Mol Cell Proteomics | 2023 | 36931626 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3635/papers?page=17